DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹2,969 Cr | ₹2,206 Cr | ₹2,369 Cr | ₹3,881 Cr | ₹2,861 Cr |
What is the latest Operating Profit of DIVIS LABORATORIES ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹2,969 Cr |
| Mar2024 | ₹2,206 Cr |
| Mar2023 | ₹2,369 Cr |
| Mar2022 | ₹3,881 Cr |
| Mar2021 | ₹2,861 Cr |
How is Operating Profit of DIVIS LABORATORIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,969 Cr | 34.59 | |
| Mar2024 | ₹2,206 Cr | -6.88 | |
| Mar2023 | ₹2,369 Cr | -38.96 | |
| Mar2022 | ₹3,881 Cr | 35.65 | |
| Mar2021 | ₹2,861 Cr | - | |
Compare Operating Profit of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹182,796.8 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
| MANKIND PHARMA | ₹102,422.0 Cr | -0.6% | 11% | -1.8% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 0.8% |
9.5% |
4.2% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses